Analysis of the plasma metalloproteome by SEC-ICP-AES: Bridging proteomics and metabolomics

Expert Review of Proteomics

Volumn 6, Issue 3, 2009, Pages 251-265

  Manley, Shawn A ^a   Gailer, Jürgen ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Diagnosis; Inductively coupled plasma atomic emission spectroscopy; Metalloprotein; Proteomics; Size exclusion chromatography; Wilson's disease

Indexed keywords

BLOOD CLOTTING FACTOR 7; CERULOPLASMIN; COPPER; CYTOKINE; FERRITIN; IRON; ISOPROTEIN; METALLOPROTEIN; PLASMA PROTEIN; PROTEIN TAG; ZINC;

ATOMIC EMISSION SPECTROMETRY; BIOLOGICAL MONITORING; BLOOD ANALYSIS; ELECTROSPRAY; FERRITIN BLOOD LEVEL; GEL PERMEATION CHROMATOGRAPHY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; IMMUNOAFFINITY CHROMATOGRAPHY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; METABOLOMICS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN CONTENT; PROTEOMICS; REVIEW; SODIUM RETENTION; TANDEM MASS SPECTROMETRY;

ANIMALS; CHROMATOGRAPHY, GEL; HUMANS; METABOLOMICS; METALLOPROTEINS; PROTEOME; PROTEOMICS; SPECTROPHOTOMETRY, ATOMIC;

EID: 66949140491     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.09.44     Document Type: Review

References (100)

1. Centers of Disease Control and Prevention, Third National Report on Human Exposure to Environmental Chemicals. CDC, Atlanta, GA, USA (2005). • Most recent report regarding the exposure of the US population to environmental chemicals based on biomonitoring studies.
2. Kim, KR, Lee SW, Paik NW, Choi K. Low-level lead exposure among South Korean lead workers, and estimates of associated risk of cardiovascular diseases. J. Occup. Environ. Hyg. 5, 399-416 (2008).
3. Ge, K, Yang G. The epidemiology of selenium deficiency in the etiological study of endemic diseases in China. Am. J. Clin. Nutr. 57(Suppl.), 259S-263S (1993). (Pubitemid 23042011)
4. Craig WY, Ledue TB, Ritchie RF. Plasma Proteins. Clinical Utility and Interpretation, FfB Research (Ed.). Dade Behring Inc., Newark, DE, USA (2000).
5. Di Serio F, Antonelli G, Trerotoli P, Tampoia M, Matarrese A, Pansini N. Appropriateness of point-of-care testing (POCT) in an emergency department. Clin. Chim. Acta 333, 185-189 (2003). (Pubitemid 36773969)
6. Zhang, H, Liu AY, Loriaux P et al. Mass spectrometric detection of tissue proteins in plasma. Mol. Cell. Proteomics 6, 64-71 (2007). (Pubitemid 46152692)
7. Conolly RB. Biologically motivated quantitative models and the mixture toxicity problem. Toxicol. Sci. 63, 1-2 (2001). (Pubitemid 32799016)
8. Carpenter DO, Arcaro K, Spink DC. Understanding the human health effects of chemical mixtures. Environ. Health Perspect. 110(Suppl. 1), 25-42 (2002). (Pubitemid 34163091)
9. Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu. Rev. Nutr. 22, 439-458 (2002). (Pubitemid 35221468)
10. Ganyc D, Talbot S, Konate F et al. Impact of trivalent arsenicals on selenoprotein synthesis. Environ. Health Perspect. 115, 346-353 (2007). (Pubitemid 46554431)
11. Talbot S, Nelson R, Self WT. Arsenic trioxide and auranofin inhibit selenoprotein synthesis: implications for chemotherapy for acute promyleocytic leukemia. Br. J. Pharmacol. 154, 940-945 (2008). (Pubitemid 351915063)
12. Gailer J. Reactive selenium metabolites as targets of toxic metals/metalloids in mammals: a molecular toxicological perspective. Appl. Organometal. Chem. 16, 701-707 (2002).
13. Gailer J. Arsenic-selenium and mercury-selenium bonds in biology. Coord. Chem. Rev. 251, 234-254 (2007). •• Provides a perspective on disease relevant antagonistic in vivo interactions between toxic metals/metalloids and the essential ultratrace element selenium in mammalian organisms.
14. Gailer J, George GN, Pickering IJ, Buttigieg GA, Denton MB, Glass RS. Synthesis, x-ray absorption spectroscopy and purification of the seleno-bis (S-glutathionyl) arsinium anion from selenide, arsenite and glutathione. J. Organometal. Chem. 650, 108-113 (2002). (Pubitemid 34441021)
15. 2-. Biochim. Biophys. Acta 372, 255-265 (1974).
16. Palkar PS, Kakhniashvili DG, Goodman SR, Mehendale HM. The rat red blood cell proteome is altered by priming with 2-butoxyethanol. Toxicol. Appl. Pharmacol. 230, 338-345 (2008).
17. Schipper HM. The role of biologic markers in the diagnosis of Alzheimer's disease. Alzheimers Dement. 3, 325-332 (2007). (Pubitemid 47553567)
18. Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics 1, 845-867 (2002). •• Comprehensively summarizes the problems that are inherently associated with the analysis of the mammalian plasma proteome.
19. Burns ER, Goldberg SN, Lawrence C, Wenz B. Clinical utility of serum tests for iron deficiency in hospitalized patients. Am. J. Clin. Pathol. 93, 240-245 (1990). (Pubitemid 20068427)
20. Service RF. Proteomics ponders prime time. Science 321, 1758-1761 (2008). • Focuses on methodological problems and promising new approaches for a comprehensive proteome analysis by mass spectrometry.
21. Adkins, JN, Varnum SM, Auberry KJ et al. Toward a human blood serum proteome. Mol. Cell. Proteomics 1, 947-955 (2002).
22. Pieper R, Gatlin CL, Makusky AJ et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two-dimensional electrophoresis gels and identification of 325 distint peaks. Proteomics 3, 1345-1364 (2003). (Pubitemid 36929557)
23. Wrotnowski C. The future of plasma proteins. Genet. Eng. News 18, 14 (1998).
24. Shen Y, Jacobs JM, Camp DGI et al. Ultra-high-efficiency strong cation exchange LC/RPLC/MS/MS for high dynamic range characterization of the human plasma proteome. Anal. Chem. 76, 1134-1144 (2004). (Pubitemid 38235564)
25. Harry JL, Wilkins MR, Herbert BR, Packer NH, Gooley AA, Williams KL. Proteomics: capacity versus utility. Electrophoresis 21, 1071-1081 (2000).
26. Rodriguez SA, Gonzalez EB, Llamas GA, Montes-Bayon M, Sanz-Medel A. Detection of transferrin isoforms in human serum: comparison of UV and ICP-MS detection after CZE and HPLC separations. Anal. Bioanal. Chem. 383, 390-397 (2005). (Pubitemid 41500612)
27. Hollenbach B, Morgenthaler NG, Struck J et al. New assay for the measurement of selenoprotein P as a sepsis biomarker from serum. J. Trace Elem. Med. Biol. 22, 24-32 (2008).
28. Paynter DI. Differences between serum and plasma ceruloplasmin activities and copper concentrations: investigation of possible contributing factors. Aust. J. Biol. Sci. 35, 353-361 (1982).
29. Klose J. Protein mapping by combined isoelectric focussing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26, 231-243 (1975).
30. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250, 4007-4021 (1975).
31. Kulkarni PP, She YM, Smith SD, Roberts EA, Sarkar B. Proteomics of metal transport and metal-associated diseases. Chem. Eur. J. 12, 2410-2422 (2006).
32. Klose J, Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16, 1034-1059 (1995).
33. Wolters DA, Washburn MP, Yates JRI. An automated multidimensional protein identification technology for shotgun proteomics. Anal. Chem. 73, 5683-5690 (2001). (Pubitemid 33126725)
34. Rabilloud T. Two-dimensional gel electrophoresis in proteomics: old, old fashioned, but it still climbs up the mountains. Proteomics 2, 3-10 (2002). (Pubitemid 34273093)
35. Righetti, PG, Boschetti E. The proteominer and the fortyniners: searching for gold nuggest in the proteomic arena. Mass Spec. Rev. 27, 596-608 (2008).
36. Dugo P, Cacciola F, Kumm T, Dugo G, Mondello L. Comprehensive multidimensional liquid chromatography: theory and applications. J. Chromatogr. A 1184, 353-368 (2008). (Pubitemid 351296208)
37. Washburn MP, Wolters D, Yates JRI. Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 19, 242-247 (2001). (Pubitemid 32220565)
38. Linke T, Ross AC, Harrison EH. Proteomic analysis of rat plasma by two-dimensional liquid chromatography and matrix-assisted laser desorption time-of-flight mass spectrometry. J. Chromatogr. A 1123, 160-169 (2006). (Pubitemid 44137357)
39. Wagner K, Miliotis T, Marko-Varga G, Bischoff, R Unger KK. An automated on-line multidimensional HPLC system for protein and peptide mapping with integrated sample preparation. Anal. Chem. 74, 809-820 (2002). (Pubitemid 34160547)
40. Stoll DR, Li X, Wang X, Carr PW, Porter SEG, Rutan SC. Fast, comprehensive two-dimensional liquid chromatography. J. Chromatogr. A 1168, 3-43 (2007). (Pubitemid 47488336)
41. Sennels L, Salek M, Lomas L, Boschetti E, Righetti PG, Rappsilber J. Proteomic analysis of human blood serum using peptide library beads. J. Proteome Res. 6, 4055-4062 (2007). (Pubitemid 350032568)
42. Zhou Y, Aebersold R, Zhang H. Isolation of N-linked glycopeptides from plasma. Anal. Chem. 79, 5826-5837 (2007). (Pubitemid 47229834)
43. Oda Y, Nagasu T, Chait BT. Enrichment analysis of phosphorylated proteins as a tool for probing the phosphoproteome. Nat. Biotechnol. 19, 379-382 (2001). (Pubitemid 32275350)
44. Leitner A, Lindner W. Chemistry meets proteomics: the use of chemical tagging reactions for MS-based proteomics. Proteomics 6, 5418-5434 (2006). • Provides a comprehensive overview of current chemical-tagging concepts for subsequent proteomic analysis by mass spectrometry.
45. Curran DP. Fluorous tags unstick messy chemical biology problems. Science 321, 1645-1646 (2008).
46. Wang SW, Zhang X, Regnier FE. Quantitative proteomics strategy involving the selection of peptides containing both cysteine and histidine from tryptic digests of cell lysates. J. Chromatogr. A 949, 153-162 (2002). (Pubitemid 34183423)
47. Wu C-C, Peng P-H, Chang Y-T et al. Identification of potential serum markers for nasopharyngal carcinoma from a xenografted mouse model using Cy-labeling combined with three-dimensional fractionation. Proteomics 8, 3605-3620 (2008).
48. Ahrends R, Pieper S, Kuehn A et al. A metal-coded affinity tag approach to quantitative proteomics. Mol. Cell. Proteomics 6, 1907-1916 (2007). (Pubitemid 350213867)
49. Liu T, Qian W-J, Gritsenko MA et al. Human plasma N-glycoproteome analysis by immunoaffinity subtraction, hydrazide chemistry, and mass spectrometry. J. Proteome Res. 4, 2070-2080 (2005). (Pubitemid 41814273)
50. Porath J, Olin B. Immobilized metal ion affinity adsorption and immobilized metal ion affinity chromatography of biomaterials. Serum protein affinities for gel-immobilized iron and nickel ions. Biochemistry 22, 1621-1630 (1983).
51. Hermanson GT. Bioconjugate Techniques (2nd Edition). Academic Press (Elsevier), MA, USA (2008).
52. Crich D, Krishnamurthy V, Hutton TK. Allylic selenosulfide rearrangement: a method for chemical ligation to cysteine and other thiols. J. Am. Chem. Soc. 128, 2544-2545 (2006). (Pubitemid 43327925)
53. Williams RJ, Lipowska M, Patonay G, Strekowski L. Comparison of covalent and non-covalent labeling with near-infrared dyes for the high-performance liquid chromatographic determination of human serum albumin. Anal. Chem. 65, 601-605 (1993). (Pubitemid 23966824)
54. Yan W, Sloat AL, Yagi S, Nakazumi H, Colyer CL. Protein labeling with red squarylium dyes for analysis by capillary electrophoresis with laser-induced fluorescence detection. Electrophoresis 27, 1347-1354 (2006).
55. Holm RH, Kennepohl P, Solomon EI. Structural and functional aspects of metal sites in biology. Chem. Rev. 96, 2239-2314 (1996). (Pubitemid 126641104)
56. Gomez-Ariza JL, Garcia-Barrera T, Lorenzo F, Arias A. Analytical characterization of bioactive metal species in the cellular domain (metallomics) to simplify environmental and biological proteomics. Intern. J. Environ. Anal. Chem. 85, 255-266 (2005). (Pubitemid 43879389)
57. Kaim W, Schwederski B. Bioanorganische Chemie. B.G. Teubner, Stuttgart, Germany (1991).
58. Manley SA, Byrns S, Lyon AW, Brown P, Gailer J. Simultaneous Cu-, Fe-, and Zn-specific detection of metalloproteins contained in rabbit plasma by sizeexclusion chromatography-inductively coupled plasma atomic emission spectroscopy. J. Biol. Inorg. Chem. 14, 61-74 (2009). •• Describes the systematic development of a bioanalytical method for the analysis of the plasma metalloproteome based on size-exclusion chromatography coupled with an inductively coupled plasma atomic-emission spectrometer.
59. Dawson JB, Bahreyni-Toosi MH, Ellis DJ, Hodgkinson A. Separation of proteinbound copper and zinc in human plasma by means of gel filtration - ion-exchange chromatography. Analyst 106, 153-159 (1981). (Pubitemid 11132702)
60. Muniz CS, Gayon JMM, Alonso JIG, Sanz-Medel A. Speciation of essential elements in human serum using anion-exchange chromatography coupled to post-column isotope dilution analysis with double focussing ICP-MS. J. Anal. At. Spectrom. 16, 587-592 (2001). (Pubitemid 32576283)
61. Michalke B. The coupling of LC to ICP-MS in element speciation: part I. General aspects. TRAC Trends Anal. Chem. 21, 142-153 (2002). (Pubitemid 34258566)
62. Szpunar J. Advances in analytical methodology for bioinorganic speciation analysis: metallomics, metalloproteomics and heteroatom-tagged proteomics and metabolomics. Analyst 130, 442-465 (2005). (Pubitemid 40523241)
63. Prange A, Proefrock D. Chemical labels and natural element tags for the quantitative analysis of bio-molecules. J. Anal. At. Spectrom. 23, 432-459 (2008).
64. Palacios O, Encinar JR, Bertin G, Lobinski R. Analysis of the selenium species distribution in cow blood by size exclusion liquid chromatography- inductively coupled plasma collision cell mass spectrometry (SEC-ICPccMS). Anal. Bioanal. Chem. 383, 516-522 (2005). (Pubitemid 41500629)
65. Hill SJ, Fisher A, Foulkes M. Basic concepts and instrumentation for plasma spectrometry. In: Inductively Coupled Plasma Spectrometry and its Applications. Hill SJ (Ed.). Blackwell Publishing, IA, USA, 61-97 (2007).
66. Bonetti A, Monica C, Bonaguri C et al. Interference by heterophilic antibodies in immunoassays: wrong increase of myoglobin values. Acta. Biomed. 79, 140-143 (2008).
67. Blanco M, Varela C. Interference from heterophilic antibodies in the Olympus ferritin method. Clin. Chem. 52, 1623-1624 (2006). (Pubitemid 44148341)
68. Kricka LJ. Human anti-animal antibody interferences in immunological assays. Clin. Chem. 45, 942-956 (1999). (Pubitemid 29340529)
69. Levinson SS, Miller JJ. Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays. Clin. Chim. Acta 325, 1-15 (2002). (Pubitemid 35279621)
70. Chesters JK, Will M. Zinc transport proteins in plasma. Br. J. Nutr. 46, 111-118 (1981). (Pubitemid 11012214)
71. Kakhniashvili DG, Bulla LA Jr, Goodman SR. The human erythrocyte proteome. Mol. Cell. Proteomics 3, 501-509 (2004).
72. Pasini, EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108, 791-801 (2006). (Pubitemid 44154609)
73. Kessler H, Pajonk F-G, Meisser P et al. Cerebrospinal fluid diagnostic markers correlate with lower plasma copper and ceruloplasmin in patients with Alzheimer's disease. J. Neural Transm. 113, 1763-1769 (2006). (Pubitemid 44657672)
74. Meret S, Henkin RI. Simultaneous direct estimation by atomic absorption spectrophotometry of copper and zinc in serum, urine, and cerebrospinal fluid. Clin. Chem. 17, 369-373 (1971).
75. Busto MED, Montes-Bayon M, Blanco-Gonzalez E, Meija J, Sanz-Medel A. Strategies to study human serum transferrin isoforms using integrated liquid chromatography ICPMS, MALDI-TOF, and ESI-Q-TOF detection: application to chronic alcohol abuse. Anal. Chem. 77, 5615-5621 (2005). (Pubitemid 41266057)
76. Paci E, Ponti A, Zappa M et al. Early diagnosis, not differential treatment, explains better survival in service screening. Eur. J. Cancer 41, 2728-2734 (2005). (Pubitemid 41607566)
77. Bush AI, Strozyk D. The role of metal ions in neurology. An introduction. Met. Ions Life Sci. 1, 1-7 (2006).
78. Akiba S, Neriishi K, Blot WJ et al. Serum ferritin and stomach cancer risk among a japanese population. Cancer 67, 1707-1712 (1991).
79. Wolf TL, Kotun J, Meador-Woodruff JH. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia. Schizophr. Res. 86, 167-171 (2006). (Pubitemid 44234055)
80. Kennard ML, Feldman H, Yamada T, Jefferies WA. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat. Med. 2, 1230-1235 (1996). (Pubitemid 26375407)
81. Williams RJP. 10th International Conference on Bioinorganic Chemistry. Florence, Italy, 10-12 August 2001.
82. Hambley TW. Metal-based therapeutics. Science 318, 1392-1393 (2007).
83. Waern JB, Dillon CT, Harding MM. Organometallic anticancer agents: cellular uptake and cytotoxicity studies on thiol derivatives of the antitumor agent molybdocene dichloride. J. Med. Chem. 48, 2093-2099 (2005). (Pubitemid 40396336)
84. Hambley TW. Developing new metal-based therapeutics: challenges and opportunities. Dalton Trans. 4929-4937 (2007). •• Highlights the conceptual advantages and the potential of metal-based drugs for the development of new drugs to treat human diseases.
85. Mandal R, Kalke R, Li X-F. Interaction of oxaliplatin, cisplatin, and carboplatin with hemoglobin and the resulting release of a heme group. Chem. Res. Toxicol. 17, 1391-1397 (2004). (Pubitemid 39391217)
86. Frisk P, Molin Y, Ilbaeck N-G. Tissue uptake of mercury is changed during the course of a common viral infection in mice. Environ. Res. 106, 178-184 (2008). (Pubitemid 351162976)
87. Edvinsson M, Frisk P, Molin Y, Hjelm E, Ilbaeck N-G. Trace element balance is changed in infected organs during acute Chlamydophila pneumoniae in mice. Biometals 21, 229-237 (2008).
88. Frisk P, Darnerud PO, Friman G, Blomberg J, Ilbaeck N-G. Sequential trace element changes in serum and blood during a common viral infection in mice. J. Trace Elem. Med. Biol. 21, 29-36 (2007). (Pubitemid 46274258)
89. Hood L, Heath JR, Phelps ME, Lin B. Systems biology and new technologies enable predictive and preventative medicine. Science 306, 640-643 (2004). (Pubitemid 39440903)
90. Lahner B, Gong J, Mahmoudian M et al. Genomic scale profiling of nutrient and trace elements in Arabidopsis thaliana. Nat. Biotechnol. 21, 1215-1221 (2003).
91. Spada PL, Rossi C, Alimonti A et al. Ferritin iron content in haemodialysis patients: comparison with septic and hemochromatosis patients. Clin. Biochem. 41, 997-1001 (2008).
92. Yamanishi H, Iyama S, Yamaguchi Y, Kanakura Y, Iwatani Y. Relation between iron content of surm ferritin and clinical status factors extracted by factor analysis in patients with hyperferritinemia. Clin. Biochem. 35, 523-529 (2002). (Pubitemid 35462127)
93. Timerbaev AR, Hartinger CG, Aleksenko SS, Keppler BK. Interactions of antitumor metallodrugs with serum proteins: advances in characterization using modern analytical methodology. Chem. Rev. 106, 2224-2248 (2006). •• Provides an overview of the advances in modern analytical methodology to study interactions between antitumor metallodrugs with serum proteins.
94. Corbin BD, Seeley EH, Raab A et al. Metal chelation and inhibition of bacterial growth in tissue abscesses. Science 319, 962-965 (2008). (Pubitemid 351263768)
95. Banin E, Lozinski A, Brady KM et al. The potential of desferrioxamine-gallium as an anti-Pseudomonas therapeutic agent. Proc. Natl Acad. Sci. USA 105, 16761-16766 (2008).
96. Becker JS, Zoriy M, Becker JS et al. Determination of phosphorus-, copper-, and zinc-containing human brain proteins by LA-ICPMS and MALDI-FTICR-MS. Anal. Chem. 77, 5851-5860 (2005). (Pubitemid 41324283)
97. Krenn BM, Holzer B, Gaudernak E, Triendl A, van Kuppeveld FJ, Seipelt J. Inhibition of polyprotein processing and RNA replication of human rhinovirus by pyrrolidine dithiocarbamate involves metal ions. J. Virol. 79, 13892-13899 (2005). (Pubitemid 41552688)
98. Korbas M, Percy AJ, Gailer J, George GN. A possible molecular link between the toxicological effects of arsenic, selenium and methylmercury: methylmercury(II) seleno bis (S-glutathionyl) arsenic(III). J. Biol. Inorg. Chem. 13, 461-470 (2008).
99. Gailer J, Irgolic KJ. The ion-chromatographic behavior of arsenite, arsenate, methylarsonic acid and dimethylarsinic acid on the Hamilton PRP-X100 anion-exchange column. Appl. Organometal. Chem. 8, 129-140 (1994).
100. Ornatsky OI, Kinach R, Bandura DR et al. Development of analytical methods for multiplex bio-assay with inductively coupled plasma mass spectrometry. J. Anal. At. Spectrom. 23, 463-469 (2008).